Shopping Cart
Remove All
Your shopping cart is currently empty
S1P1 Agonist III is an effective, orally active S1P1 receptor agonist with an EC₅₀ of 18 nM, S1P1 Agonist III has potential application in research related in inflammation and immunology.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $107 | - | In Stock | |
| 10 mg | $178 | - | In Stock | |
| 25 mg | $357 | - | In Stock | |
| 50 mg | $543 | - | In Stock | |
| 100 mg | $814 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $111 | - | In Stock |
| Description | S1P1 Agonist III is an effective, orally active S1P1 receptor agonist with an EC₅₀ of 18 nM, S1P1 Agonist III has potential application in research related in inflammation and immunology. |
| Targets&IC50 | S1P1:18 nM (EC50) |
| In vitro | S1P1 Agonist III demonstrates superior activity against S1P1 in Parazacco spilurus subsp. spilurus (EC50=0.035 μM, efficacy reaching 96%), with selectivity exceeding 100-fold for S1P2-5 receptor subtypes [2]. |
| In vivo | Twenty-four hours after a single oral administration of S1P1 Agonist III (1 mg/kg) in rats, the number of circulating lymphocytes significantly decreased, with a pharmacodynamic validation value (POC) of -78% [2]. |
| Molecular Weight | 415.37 |
| Formula | C21H16F3N3O3 |
| Cas No. | 1324003-64-6 |
| Smiles | O=C(NC(=O)C=1C=NC=CC1OC)NC=2C=CC(C=3C=CC=CC3)=C(C2)C(F)(F)F |
| Relative Density. | 1.354 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 48 mg/mL (115.56 mM), Sonication is recommeded. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2.5 mg/mL (6.02 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.